Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
  March 29, 2008  
  Volume IX, Issue 23  
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

  Comments in the BLOG  

You will find a newly posted BLOG with a complete update on last week's annual 10K filing of the audited financial statement from Spicy Pickle (OTC BB: SPKL). Definitely worth a read- this stock will be much higher in the next Bull Market in my view. Read my comments, and find out where it could go between now and then.

I've also started a new feature- a daily BLOG with a short review and some observations on the market and how I see it. I won't be able to publish it every day as it can be tough when traveling, but I'll try to do it as frequently as possible. Let me know if you find it valuable.

For those of you who are following my short term trading ideas in the BLOG, this past week I closed out the Lehman (NYSE: LEH) puts I suggested in last weekend's edition. I held them for two trading days- Monday and Tuesday, and closed them out on Wednesday. Happy to notch a $3,000 gain on an $8,000 high risk investment in two days, but left some money on the table by exiting early. Between GS and LEH I'm 2 for 2 on the short term ideas I've shared. Perhaps I'm due for a losing trade.

On Friday, just before the market closed, I picked up 1,000 SPY (ETF for the S&P 500) at $132.06 as posted in the BLOG. I think the larger market will bounce early next week, and I'll scalp a couple of points off this trade. 

If you want to follow these trades, you can either check the site periodically, or use the RSS Feeds to imbed the BLOG in the home page of your browser. Simply go to the home page at www.otcjournal.com and check the right hand menu bar for new postings.

The BLOG is your opportunity to ask questions and offer comments. I will make an effort to answer every legitimate question. If I don't know the answer, I will contact the management and get the answer. Alternatively, if you have questions you don't want publicly displayed, you can always email me directly at editor@otcjournal.com. If you submit a comment or question, it will not appear on the site until I have responded.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG scrolls down from the upper right hand corner. The most current journal entries appear on the right hand side of you screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels in volatile markets.
 

The Big Trade For Next Week: RIMM

I believe I have identified a really exciting trading opportunity for next week, and I want everyone to get the heads up ahead of time in the event you like the idea and want to position yourself.

Research In Motion (NASDAQ: RIMM)- makers of the widely used Blackberry (I used to have one, but I like the iPhone better) is setting up for a great trade in my view.

Here's the current chart.

Two big consumer tech names have been trading really well of late: Apple (NASDAQ: AAPL- darn it, I missed the bottom), and Research In Motion (NASDAQ: RIMM).

As you can see from the chart, RIMM has made a big comeback of late, rebounding from about $80 during the January low back to the $120 level this past week. It has been particularly strong this past week.

RIMM is announcing year end earnings after the close this coming Wednesday, and the financial media is buzzing about robust results and earnings doubling to $401 million, or $.71 per share.

This is a pattern I have seen time and time again over the years. When a stock runs up into a big earnings release, good or bad, it nearly always sells off after the fact.

If RIMM continues trading up into the event post close on Wednesday, I am going to take a fairly substantial short position by either shorting the stock or buying puts before the earnings are announced. Perhaps I'll do both.

This is certainly risky, and definitely not a suitable use of your "safe" money. However, I like the odds if RIMM keeps moving up the charts.

Here's what will happen. If the company delivers any sort of disappointment on any front, the stock will absolutely get killed. If the company delivers the numbers as expected, the stock will go down. If the company absolutely blows away the "whisper" number, the stock will trade up briefly, then probably give some ground. This market is far from out of the woods, and RIMM's reward for stellar performance is already being priced in.

If it continues to trade up into Wednesday, I will definitely be taking a short position, and advise everyone via the BLOG.

Several followers have asked me to publish these short term ideas with email additions. It's not viable. It takes about 4 hours to get it out to everyone, and in a moving market its simply too long.

Check back frequently next week if you want to know what I suggest- which will mirror my own trades.
 

  Subscribe  

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

  Refer A Friend  

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.


  Ensure Newsletter Delivery  

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Disclaimer
The OTC Journal Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

(Insert specific company compensation here)

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/?.

 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

OTCJ: Chu On This
December 16, 2008

Market Summary
Dow 8952.89 -81.80 (-0.91%)
Nasdaq 1628.03 -4.18 (-0.26%)
Russell 2K 505.03 +0.00 (+0.00%)
S&P 500 927.45 +0.00 (+0.00%)
S&P 100 440.83 +0.00 (+0.00%)
Quotes are delayed 20 minutes.

© 2009 OTC Journal